FDA Approves Novo Nordisk Obesity Drug

FDA Approves Novo Nordisk Obesity Drug

The U.S. Food and Drug Administration (FDA) recently approved Saxenda, an injectable drug developed by Novo Nordisk. Although Saxenda is a formulation of the type 2 diabetes drug, liraglutide, also known as Victoza, Saxenda has been indicated for the treatment of...
Pill Decreases Blood Glucose by 30 Percent

Pill Decreases Blood Glucose by 30 Percent

Scientists from Cornell University saw promising results in an animal study that could one day lead to the creation of a probiotic pill that can help control blood glucose. Researchers treated rats with type 2 diabetes with an oral probiotic for 90 days. The animals...
Metformin is Rarely Prescribed in People with Prediabetes

Metformin is Rarely Prescribed in People with Prediabetes

Metformin, a drug used to treat type 2 diabetes, may be underused in the prevention of the chronic disease, according to a recent study conducted by researchers at UCLA. Their study showed that throughout a three year span, 2010-2012, only 3.7 percent of U.S. adults...
Vaccine for Type 1 Advances

Vaccine for Type 1 Advances

An existing vaccination drug, Calmette-Guerin (BCG), has now been approved by the FDA for the start of phase II of a trial to determine the vaccine’s effectiveness in the treatment of type 1 diabetes. The announcement was made last week at the 75th Scientific Sessions...